In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 45 for your search:
Cancer Type/Condition:  BRCA1 mutation carrier
Stage/Subtype:  BRCA1 mutation carrier
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Screening
Status: Active
Age: 25 to 70
Sponsor: Other
Protocol IDs: DBCG07MRBRCA, NCT00413491
2.

Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: BREC-AGC, NCT01206218
3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 69
Sponsor: Other
Protocol IDs: UC-0104/0701 - ONCO03, ONCO-03/0701, EU-20806, NOVARTIS-FNCLCC-ONCO 03/0701, 2007-000687-24, FNCLCC-ONCO-03/0701, FNCLCC-ONCO 03/0701 - LIBER, NCT00673335
4.

Phase: Phase III
Type: Prevention
Status: Active
Age: 20 to 46
Sponsor: Other
Protocol IDs: IEO S462/109, 2009-010260-41, NCT01479192
5.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-001687, NCT01591746
6.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: N12OLG, 2012-000838-19, NCT01646034
7.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Veli-BRCA, NCT01472783
8.

Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: CRUK-BRCA-TRIAL, EUDRACT-2004-001496-20, EU-20603, ISRCTN43372330, BBC-CRUK-BRCA-TRIAL, NCT00321633
9.

Phase: Phase II
Type: Prevention
Status: Active
Age: 30 to 90
Sponsor: Other
Protocol IDs: 102/07 (HT4351), NCT00496288
10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000593558, CRUK-PH2-052, CRUK-PARP/BRCA, EU-20842, EUDRACT-2006-002348-27, PH2/052, NCT00664781
11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 50
Sponsor: NCI, Other
Protocol IDs: CDR0000668698, S0812, U10CA032102, SWOG-S0812, NCT01097278
12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 21 to 49
Sponsor: Other
Protocol IDs: 12377, NCT01276704
13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: M12-895, 2011-002913-12, NCT01506609
14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-00864, IRB#12-045, CDR0000732189, MSKCC-12-045, U01CA069856, P30CA008748, N01CM00071, 12-045, 8993, NCT01585805
15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 20 to 70
Sponsor: Other
Protocol IDs: BN-001/83/07-B, NCT01630226
16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01472, UPCI # 08-121, CINJ-050810, CDR0000641433, U01CA099168, U01CA062505, 8282, NCT00892736
17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 25 to 45
Sponsor: Other
Protocol IDs: 2009-015-B, NCT01022333
18.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01473, 09-012, U01CA099168, UPCI 09-012, 8324, NCT01154426
19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Screening
Status: Active
Age: 25 to 80
Sponsor: Other
Protocol IDs: P50CA83636-01, 6973, NCT01121640
20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02543, C010903, CDR0000687938, U01CA062491, WCCC-CO-10903, CO10903, 8604, NCT01233505
21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110022, 11-C-0022, NCT01237067
22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-03458, 11-144, U01CA062490, DFCI-11-144, 8484, NCT01434316
23.

Phase: No phase specified
Type: Screening
Status: Active
Age: 30 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069397, MGH-000084, NCT00039559
24.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 40 to 69
Sponsor: Other
Protocol IDs: 05/MRE07/25, CCR2598, NCT00261456
25.

Phase: No phase specified
Type: Screening
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: UHNREB#07-0689-CE, HC#124313, NCT00500383
1   
New Search